EPIX STOCK ALERT: Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into ESSA Pharma Inc. (NASDAQ:EPIX) for potential violations of federal securities laws. This follows ESSA's announcement of ending its Phase 2 trial for a prostate cancer treatment.
November 06, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ESSA Pharma Inc. is under investigation by Levi & Korsinsky for potential securities law violations after halting a Phase 2 trial for a prostate cancer treatment.
The investigation by Levi & Korsinsky into potential securities law violations is likely to create negative sentiment around ESSA Pharma's stock. The decision to end a Phase 2 trial could also impact investor confidence, leading to potential short-term price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100